Report cover image

Breast Cancer Gene (BRCA) Mutations Treatment Global Market Report 2025

Publisher The Business Research Company
Published Sep 30, 2025
Length 250 Pages
SKU # BRC20428460

Description

Breast Cancer Gene (BRCA) Mutations Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on breast cancer gene (brca) mutations treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for breast cancer gene (brca) mutations treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The breast cancer gene (brca) mutations treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Treatment Type: Targeted Therapies; Chemotherapy; Hormonal Therapy; Immunotherapy

2) By Indication: Breast Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer

3) By Administration Route: Oral; Intravenous; Subcutaneous

4) By End-User: Hospitals; Clinics; Cancer Specialty Clinics

Subsegments:

1) By Targeted Therapies: Poly (ADP-Ribose) Polymerase Inhibitors; Mammalian Target Of Rapamycin Inhibitors; Cyclin-Dependent Kinase 4 And 6 Inhibitors; Tyrosine Kinase Inhibitors

2) By Chemotherapy: Platinum-Based chemotherapy; Anthracyclines; Taxanes; Antimetabolites

3) By Hormonal Therapy: Selective Estrogen Receptor Modulators (SERMs); Aromatase Inhibitors; Selective Estrogen Receptor Degraders (SERDs); Luteinizing Hormone-Releasing Hormone (LHRH) Agonists

4) By Immunotherapy: Immune Checkpoint Inhibitors; Cancer Vaccines; Monoclonal Antibodies; Adoptive Cell Transfer (ACT)

Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Thermo Fisher Scientific Inc.; AstraZeneca PLC; Novartis AG; GSK plc; Janssen Biotech Inc.; Astellas Pharma Inc.; Agilent Technologies Inc.; Genentech Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Invitae Corporation; Guardant Health Inc.; Clovis Oncology Inc.; Owkin Inc.; Allarity Therapeutics Inc.; VBL Therapeutics

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Breast Cancer Gene (BRCA) Mutations Treatment Market Characteristics
3. Breast Cancer Gene (BRCA) Mutations Treatment Market Trends And Strategies
4. Breast Cancer Gene (BRCA) Mutations Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Breast Cancer Gene (BRCA) Mutations Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Breast Cancer Gene (BRCA) Mutations Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Breast Cancer Gene (BRCA) Mutations Treatment Market Growth Rate Analysis
5.4. Global Breast Cancer Gene (BRCA) Mutations Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Breast Cancer Gene (BRCA) Mutations Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Breast Cancer Gene (BRCA) Mutations Treatment Total Addressable Market (TAM)
6. Breast Cancer Gene (BRCA) Mutations Treatment Market Segmentation
6.1. Global Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Targeted Therapies
Chemotherapy
Hormonal Therapy
Immunotherapy
6.2. Global Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Breast Cancer
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
6.3. Global Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Subcutaneous
6.4. Global Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Cancer Specialty Clinics
6.5. Global Breast Cancer Gene (BRCA) Mutations Treatment Market, Sub-Segmentation Of Targeted Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Poly (ADP-Ribose) Polymerase Inhibitors
Mammalian Target Of Rapamycin Inhibitors
Cyclin-Dependent Kinase 4 And 6 Inhibitors
Tyrosine Kinase Inhibitors
6.6. Global Breast Cancer Gene (BRCA) Mutations Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Platinum-Based chemotherapy
Anthracyclines
Taxanes
Antimetabolites
6.7. Global Breast Cancer Gene (BRCA) Mutations Treatment Market, Sub-Segmentation Of Hormonal Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Selective Estrogen Receptor Modulators (SERMs)
Aromatase Inhibitors
Selective Estrogen Receptor Degraders (SERDs)
Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
6.8. Global Breast Cancer Gene (BRCA) Mutations Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immune Checkpoint Inhibitors
Cancer Vaccines
Monoclonal Antibodies
Adoptive Cell Transfer (ACT)
7. Breast Cancer Gene (BRCA) Mutations Treatment Market Regional And Country Analysis
7.1. Global Breast Cancer Gene (BRCA) Mutations Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Breast Cancer Gene (BRCA) Mutations Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Breast Cancer Gene (BRCA) Mutations Treatment Market
8.1. Asia-Pacific Breast Cancer Gene (BRCA) Mutations Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Breast Cancer Gene (BRCA) Mutations Treatment Market
9.1. China Breast Cancer Gene (BRCA) Mutations Treatment Market Overview
9.2. China Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Breast Cancer Gene (BRCA) Mutations Treatment Market
10.1. India Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Breast Cancer Gene (BRCA) Mutations Treatment Market
11.1. Japan Breast Cancer Gene (BRCA) Mutations Treatment Market Overview
11.2. Japan Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Breast Cancer Gene (BRCA) Mutations Treatment Market
12.1. Australia Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Breast Cancer Gene (BRCA) Mutations Treatment Market
13.1. Indonesia Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Breast Cancer Gene (BRCA) Mutations Treatment Market
14.1. South Korea Breast Cancer Gene (BRCA) Mutations Treatment Market Overview
14.2. South Korea Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Breast Cancer Gene (BRCA) Mutations Treatment Market
15.1. Western Europe Breast Cancer Gene (BRCA) Mutations Treatment Market Overview
15.2. Western Europe Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Breast Cancer Gene (BRCA) Mutations Treatment Market
16.1. UK Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Breast Cancer Gene (BRCA) Mutations Treatment Market
17.1. Germany Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Breast Cancer Gene (BRCA) Mutations Treatment Market
18.1. France Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Breast Cancer Gene (BRCA) Mutations Treatment Market
19.1. Italy Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Breast Cancer Gene (BRCA) Mutations Treatment Market
20.1. Spain Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Breast Cancer Gene (BRCA) Mutations Treatment Market
21.1. Eastern Europe Breast Cancer Gene (BRCA) Mutations Treatment Market Overview
21.2. Eastern Europe Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Breast Cancer Gene (BRCA) Mutations Treatment Market
22.1. Russia Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Breast Cancer Gene (BRCA) Mutations Treatment Market
23.1. North America Breast Cancer Gene (BRCA) Mutations Treatment Market Overview
23.2. North America Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Breast Cancer Gene (BRCA) Mutations Treatment Market
24.1. USA Breast Cancer Gene (BRCA) Mutations Treatment Market Overview
24.2. USA Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Breast Cancer Gene (BRCA) Mutations Treatment Market
25.1. Canada Breast Cancer Gene (BRCA) Mutations Treatment Market Overview
25.2. Canada Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Breast Cancer Gene (BRCA) Mutations Treatment Market
26.1. South America Breast Cancer Gene (BRCA) Mutations Treatment Market Overview
26.2. South America Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Breast Cancer Gene (BRCA) Mutations Treatment Market
27.1. Brazil Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Breast Cancer Gene (BRCA) Mutations Treatment Market
28.1. Middle East Breast Cancer Gene (BRCA) Mutations Treatment Market Overview
28.2. Middle East Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Breast Cancer Gene (BRCA) Mutations Treatment Market
29.1. Africa Breast Cancer Gene (BRCA) Mutations Treatment Market Overview
29.2. Africa Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Breast Cancer Gene (BRCA) Mutations Treatment Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Breast Cancer Gene (BRCA) Mutations Treatment Market Competitive Landscape And Company Profiles
30.1. Breast Cancer Gene (BRCA) Mutations Treatment Market Competitive Landscape
30.2. Breast Cancer Gene (BRCA) Mutations Treatment Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
31. Breast Cancer Gene (BRCA) Mutations Treatment Market Other Major And Innovative Companies
31.1. Novartis AG
31.2. GSK plc
31.3. Janssen Biotech Inc.
31.4. Astellas Pharma Inc.
31.5. Agilent Technologies Inc.
31.6. Genentech Inc.
31.7. Illumina Inc.
31.8. Bio-Rad Laboratories Inc.
31.9. QIAGEN N.V.
31.10. Invitae Corporation
31.11. Guardant Health Inc.
31.12. Clovis Oncology Inc.
31.13. Owkin Inc.
31.14. Allarity Therapeutics Inc.
31.15. VBL Therapeutics
32. Global Breast Cancer Gene (BRCA) Mutations Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Breast Cancer Gene (BRCA) Mutations Treatment Market
34. Recent Developments In The Breast Cancer Gene (BRCA) Mutations Treatment Market
35. Breast Cancer Gene (BRCA) Mutations Treatment Market High Potential Countries, Segments and Strategies
35.1 Breast Cancer Gene (BRCA) Mutations Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Breast Cancer Gene (BRCA) Mutations Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Breast Cancer Gene (BRCA) Mutations Treatment Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us